Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2

Toxicology and Applied Pharmacology

Volumn 150, Issue 2, 1998, Pages 295-300

  Bazin Redureau, M ^a   Pepin, S ^a   Hong, G ^a   Debray, M ^b   Scherrmann, J M ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Clearance; F(ab')2 fragments; Interspecies scaling; Pharmacokinetics; Volume of distribution

Indexed keywords

IMMUNOGLOBULIN F(AB')2 FRAGMENT; IODINE 125; VENOM ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MODEL; MOUSE; NONHUMAN; RABBIT; RAT; SPECIES DIFFERENCE; TECHNIQUE;

ANIMALIA; EQUUS CABALLUS; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032102440     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8363     Document Type: Article

References (22)

1. Arend W. P., Silverblatt F. J. Serum disappearance and catabolism of homologous immunoglobulin fragments in rats. Clin. Exp. Immunol. 22:1975;502-513.
2. 2. J. Pharm. Pharmacol. 49:1997;277-281.
3. Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. J. Pharmacokinet. Biopharm. 8:1980;165-176.
4. Boxenbaum H. Interspecies scaling, allometry, physiological time and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm. 10:1982;201-227.
5. Boxenbaum H., Ronfeld R. Interspecies pharmacokinetic scaling and the Dedrick plots. Am. J. Physiol. 245:1983;R768-R775.
6. Butler V. P., Schmidt D. H., Smith T. W. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. J. Clin. Invest. 59:1977;345-359.
7. Callagan T. A., Fleetwood P., Contreras M., Molisson P. L., Scherrmann J. M. Human monoclonal anti-D with a normal half-life. Transfusion. 33:1993;784-785.
8. Dedrick R. L., Bischoff K. B., Zaharko D. Z. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother. Rep., Part I. 54:1970;95-101.
9. Fraker P. J., Speck J. C. Protein and cell membranes iodinations with a sparingly soluble chloramide 1,3,4,6-tetra-chloro-3α-6α-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:1978;849-857.
10. Gibaldi, M. Perrier, D. 1982, Pharmacokinetics, 199, 219, Dekker, New York.
11. Grene-Lerouge N., Bazin-Redureau M., Debray M., Scherrmann J. M. Interspecies scaling of clearance and volume of distribution for digoxin-specific Fab. Toxicol. Appl. Pharmacol. 138:1996;84-89.
12. 111. Cancer Res. 47:1987;6111-6117.
13. Ho M., Silamut K., White N., Karbwang J., Looareesuwan S., Phillips R., Warrell D. Pharmacokinetics of three commercial antivenoms in patients envenomed by the malayan pit viper,Calloselasma rhodostoma, Am. J. Trop. Med. Hyg. 42:1990;260-266.
14. Keyler D. E., Salerno D. M., Murakami M. M., Ruth G., Pentel P. R. Rapid administration of high-dose human antibody Fab fragments to dogs: Pharmacokinetics and toxicity. Fundam. Appl. Toxicol. 17:1991;83-91.
15. Lave T., Levet-Trafit B., Schmitt-Hoffmann A., Morgenroth B., Richter W., Chou R. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations. J. Pharm. Sci. 84:1995;1285-1290.
16. Mordenti J. Pharmacokinetic scale-up: Accurate prediction of human pharmacokinetic profiles from animal data. J. Pharm. Sci. 74:1985;1097-1099.
17. Mordenti J., Chen S. A., Moore J. A., Ferraiolo B. L., Green J. G. Interspecies scaling of clearance and volume of distribution data for five therapeutics proteins. Pharm. Res. 8:1991;1351-1359.
18. 2. Toxicol. Appl. Pharmacol. 141:1996;272-277.
19. Sabouraud A., Urtizberea M., Cano N., Grandgeorge M., Rouzioux J. M., Scherrmann J. M. Colchicine-specific Fab fragments alter colchicine disposition in rabbits. J. Pharmacol. Exp. Ther. 260:1992;1214-1219.
20. Schaumann W., Kaufmann B., Neubert P., Smolarz A. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. Eur. J. Clin. Pharmacol. 30:1986;527-533.
21. Scherrmann J. M., Terrien N., Urtizberea M., Pierson P., Denis H., Bourre J. M. Immunotoxicotherapy: Present status and future trends. J. Toxicol. Clin. Toxicol. 27:1989;1-35.
22. 2. J. Nucl. Med. 24:1983;316-325.